Bill115th CongressFiled Jul 31, 2017Health
S. 1681
A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (Jul 31, 2017)
This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.
What just happenedJul 31, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
Sen. Sanders, Bernard [I-VT](I-VT)Sponsor
1committees2actions1related bills7subjects
- Introduced in SenateJul 31, 2017
- Jul 31, 2017IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - Jul 31, 2017IntroReferral10000
Introduced in Senate